+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Colorectal Cancer Screening & Diagnostic Market by Product Type, Age Group, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5925069
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Colorectal Cancer Screening & Diagnostic Market grew from USD 15.29 billion in 2023 to USD 16.21 billion in 2024. It is expected to continue growing at a CAGR of 6.28%, reaching USD 23.43 billion by 2030.

The scope of the colorectal cancer screening and diagnostic market encompasses various methodologies, including fecal tests, endoscopic procedures, and imaging techniques, aimed at early detection to improve treatment outcomes. Within this domain, the necessity arises from the high mortality associated with late-stage colorectal cancer, emphasizing early detection as crucial for reducing death rates. These screenings and diagnostics are applied in hospitals, diagnostic labs, and other healthcare settings, facilitating timely intervention. The market's end-use scope covers a broad spectrum from individual wellness screening programs to large-scale public health initiatives. Key factors influencing market growth include increasing awareness of early cancer detection, advancements in technology such as non-invasive diagnostics, and supportive governmental policies. Moreover, the rising geriatric population also propels demand. Latest opportunities in this field lie in the integration of AI and machine learning to enhance precision in diagnostics and personalized medicine approaches. Companies can capitalize on these trends by investing in R&D to innovate less invasive, more cost-effective solutions that offer high accuracy. However, market growth faces challenges such as high costs of advanced diagnostic procedures, disparities in access to quality healthcare, and resistance to undergoing invasive tests. Further, regulatory hurdles in approving new devices pose additional challenges. Innovation should focus on enhancing the sensitivity and specificity of non-invasive tests and developing home-based diagnostic kits that improve accessibility and compliance. Collaborations with technology firms to create AI-driven tools that assist in accurate prognosis could lead to breakthroughs. The market is dynamic and competitive, driven by technological advancements and the demand for personalized care solutions, offering numerous opportunities for businesses willing to navigate the regulatory complexities and invest in cutting-edge research and development.

Understanding Market Dynamics in the Colorectal Cancer Screening & Diagnostic Market

The Colorectal Cancer Screening & Diagnostic Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing cases of colorectal cancer globally
    • Rising government initiatives to promote early detection of colorectal cancer
  • Market Restraints
    • High cost associated with colorectal cancer screening and diagnostic
  • Market Opportunities
    • Growing funding and expenditure in the healthcare sector for cancer diagnosis and treatment
    • Increase in the launch of new and advanced cancer diagnostic technologies
  • Market Challenges
    • Concerns associated with post-colonoscopy complications

Exploring Porter’s Five Forces for the Colorectal Cancer Screening & Diagnostic Market

Porter’s Five Forces framework further strengthens the insights of the Colorectal Cancer Screening & Diagnostic Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Colorectal Cancer Screening & Diagnostic Market

External macro-environmental factors deeply influence the performance of the Colorectal Cancer Screening & Diagnostic Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Colorectal Cancer Screening & Diagnostic Market

The Colorectal Cancer Screening & Diagnostic Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Colorectal Cancer Screening & Diagnostic Market

The Colorectal Cancer Screening & Diagnostic Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Colorectal Cancer Screening & Diagnostic Market

The Colorectal Cancer Screening & Diagnostic Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Colorectal Cancer Screening & Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Clinical Genomics Technologies Pty Ltd., Eiken Chemical Co., Ltd., Epigenomics AG, Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guardant Health, Hologic, Inc., Illumina, Inc., KARL STORZ SE & Co. KG, Medtronic PLC, Merck KGaA, Myriad Genetics, Inc., Novigenix SA, Olympus Corporation, Prenetics Global Limited, QIAGEN N.V., Quest Diagnostics Incorporated, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Colorectal Cancer Screening & Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Instruments
    • Reagents & Kits
  • Age Group
    • 19 to 65
    • Above 65
    • Upto 18 Years
  • End-use
    • Clinical Laboratories
    • Diagnostic Imaging Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of colorectal cancer globally
5.1.1.2. Rising government initiatives to promote early detection of colorectal cancer
5.1.2. Restraints
5.1.2.1. High cost associated with colorectal cancer screening and diagnostic
5.1.3. Opportunities
5.1.3.1. Growing funding and expenditure in the healthcare sector for cancer diagnosis and treatment
5.1.3.2. Increase in the launch of new and advanced cancer diagnostic technologies
5.1.4. Challenges
5.1.4.1. Concerns associated with post-colonoscopy complications
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Colorectal Cancer Screening & Diagnostic Market, by Product Type
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
7. Colorectal Cancer Screening & Diagnostic Market, by Age Group
7.1. Introduction
7.2. 19 to 65
7.3. Above 65
7.4. Upto 18 Years
8. Colorectal Cancer Screening & Diagnostic Market, by End-use
8.1. Introduction
8.2. Clinical Laboratories
8.3. Diagnostic Imaging Centers
8.4. Hospitals & Clinics
9. Americas Colorectal Cancer Screening & Diagnostic Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Colorectal Cancer Screening & Diagnostic Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Colorectal Cancer Screening & Diagnostic Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET DYNAMICS
TABLE 7. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY 19 TO 65, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY ABOVE 65, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY UPTO 18 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 30. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. NORWAY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 114. POLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. QATAR COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. SPAIN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 138. TURKEY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Colorectal Cancer Screening & Diagnostic Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Clinical Genomics Technologies Pty Ltd.
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Novigenix SA
  • Olympus Corporation
  • Prenetics Global Limited
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information